These updated guidelines provide recommendations for the treatment of adults with spasticity with botulinum toxin as part of an overall patient management programme.
This guideline covers treatments for people aged 18 and over with unstable angina (recurring chest pain) or a type of heart attack called non-ST-segment-elevation myocardial infarction (NSTEMI). It aims to ensure that people get treatment quickly.
